The coordinated sale by two 10% owners at the same price on the same day is a strong bearish signal for a micro-cap biotech. Monitor for upcoming 8-K filings (earnings, clinical updates, or financing) that may have motivated the sales. The 3.5% market cap stake sold is too large to ignore, but the absence of C-suite participation tempers the signal slightly.
Price Chart
Executive Summary
Two 10% owners of Sensei Biotherapeutics sold a combined $981K in open-market sales at $20/share, representing ~3.5% of the company's $28M market cap. This is a highly material insider cluster relative to company size, though both sellers are 10% owners rather than C-suite executives, which slightly reduces the informational signal. The cluster occurs without any disclosed 10b5-1 plan context, and the symmetrical timing and size suggest coordinated selling.
Key Financial Metrics
Key Facts
- Two 10% owners sold a combined 49,048 shares for $981K at $20/share on June 1, 2026
- Total sales represent ~3.5% of SNSE's $28M market cap, exceeding the 2% materiality threshold
- No 10b5-1 plans or regular selling patterns disclosed; sales appear coordinated
- No C-suite insiders (CEO/CFO) participated in the cluster, reducing predictive power vs. executive-led clusters
- Recent insider activity shows $981K in total sales over 30 days, all from this cluster
Financial Impact
Sales of $981K represent ~3.5% of market cap, highly material for a $28M company
Risk Factors
- Potential undisclosed negative catalyst (clinical trial failure, financing need, regulatory setback)
- Further insider selling could accelerate if remaining 10% owners follow suit
- Micro-cap liquidity risk: $981K in sales could pressure the stock in thin trading
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SNSE-1780348937544 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 16, 2026 18w ago | 3 | $13.86 | awaiting T+5 | — | — |
Jun 15, 2026 19w ago | 8-K | $13.04 | awaiting T+5 | — | — |
Jun 15, 2026 19w ago | EFFECT | $13.04 | awaiting T+5 | — | — |
Jun 10, 2026 19w ago | S-3/A | $10.79 $13.85 | ▲ +28.36% | ▲ +27.93% | — |
Jun 10, 2026 19w ago | 8-K | $10.79 $13.85 | ▲ +28.36% | ▲ +27.93% | — |
Jun 2, 2026 21w ago | 10-K/A | $16.10 $12.63 | ▼ −21.53% | ▼ −18.56% | — |
Jun 2, 2026 21w ago | S-3/A | $16.10 $12.63 | ▲ +21.53% | ▲ +18.56% | — |
Jun 1, 2026 21w ago | Insider Cluster | $16.10 $12.63 | ▲ +21.53% | ▲ +18.56% | — |
May 22, 2026 22w ago | DEFA14A | $16.47 $19.79 | ▲ +20.16% | ▲ +19.07% | — |
May 22, 2026 22w ago | 8-K | $16.47 $19.79 | ▲ +20.16% | ▲ +19.07% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers